Status:
RECRUITING
Nutritional Therapy Enriched With Omega-3 in Patients With Lung Resection
Lead Sponsor:
National Institute of Respiratory Diseases, Mexico
Conditions:
Lung Cancer
Surgery
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to analyze the effect of enriched formula with omega-3 in the 30-day incidence infection and inflammatory response following lung resection surgery in lung cancer patients.
Eligibility Criteria
Inclusion
- Lung cancer diagnosis
- Elective surgery for lung resection schedule at least four days before surgery
- Signed informed consent.
Exclusion
- Acute or chronic organ failure as hepatic or renal insufficiency
- Patients with fish-allergy
- History of any surgery within 3 months
- Immunocompromised patients
Key Trial Info
Start Date :
July 25 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2027
Estimated Enrollment :
310 Patients enrolled
Trial Details
Trial ID
NCT06531460
Start Date
July 25 2024
End Date
July 1 2027
Last Update
August 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Respiratory Diseases
Mexico City, Mexico, 14080